We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.2M
AUM Growth
-$16M
Cap. Flow
-$12.8M
Cap. Flow %
-13.02%
Top 10 Hldgs %
57.17%
Holding
92
New
14
Increased
16
Reduced
24
Closed
27

Top Buys

Rank Stock Value
1
DRRX
DURECT Corp
DRRX
+$1.78M
2
BKNG icon
Booking.com
BKNG
+$1.68M
3
RTK
Rentech, Inc.
RTK
+$1.66M
4
CSII
Cardiovascular Systems, Inc.
CSII
+$1.33M
5
CDZI icon
Cadiz
CDZI
+$1.16M

Top Sells

Rank Stock Value
1
SYT
Syngenta Ag
SYT
+$6.05M
2
LSAK icon
Lesaka Technologies
LSAK
+$3.8M
3
TLPH icon
Talphera
TLPH
+$2.99M
4
CUTR
Cutera, Inc.
CUTR
+$1.56M
5
DRTX
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
+$1.42M

Sector Composition

Rank Sector Weight
1 Healthcare 44.84%
2 Technology 18.47%
3 Financials 8.1%
4 Communication Services 7.26%
5 Materials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NES
26
DELISTED
NUVERRA ENVIRONMENTAL INC NEW COM STK (DE)
NES
$1.05M 1.07%
52,300
-25,100
-32% -$445K
ENVI
27
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$1.04M 1.06%
435,322
-107,300
-20% -$277K
CKSW
28
DELISTED
CLICKSOFTWARE TECH LTD
CKSW
$1.02M 1.04%
+126,700
New +$1.09M
AVAV icon
29
AeroVironment
AVAV
$7.74B
$999K 1.02%
31,400
+18,700
+147% +$634K
TROX icon
30
Tronox
TROX
$877M
$944K 0.96%
+35,100
New +$898K
WATT icon
31
Energous
WATT
$65.4M
$935K 0.95%
+103
New +$749K
SCTL
32
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$810K 0.82%
112,615
+30,662
+37% +$186K
CYNI
33
DELISTED
CYAN INC COM
CYNI
$736K 0.75%
182,699
-43,000
-19% -$172K
SILC icon
34
Silicom
SILC
$274M
$627K 0.64%
+15,000
New +$737K
AVG
35
DELISTED
AVG Technologies N.V.
AVG
$612K 0.62%
30,400
– –
EXAS
36
DELISTED
Exact Sciences
EXAS
$540K 0.55%
+31,700
New +$436K
TPST icon
37
Tempest Therapeutics
TPST
$17.9M
$510K 0.52%
19
– –
ARWR icon
38
Arrowhead Research
ARWR
$12.5B
$508K 0.52%
35,458
-13,500
-28% -$177K
ETRM
39
DELISTED
EnteroMedics Inc.
ETRM
$468K 0.48%
+286
New +$535K
UPI
40
DELISTED
UROPLASTY INC-NEW
UPI
$463K 0.47%
172,600
– –
ININ
41
DELISTED
Interactive Intelligence Group, inc.
ININ
$456K 0.46%
+8,100
New +$464K
EVOK
42
DELISTED
Evoke Pharma
EVOK
$397K 0.4%
340
– –
SQNS
43
Sequans Communications SA
SQNS
$44.3M
$387K 0.39%
2,250
-956
-30% -$186K
TLGT
44
DELISTED
Teligent, Inc
TLGT
$330K 0.34%
+6,250
New +$319K
MNDT
45
DELISTED
Mandiant, Inc. Common Stock
MNDT
$289K 0.29%
7,100
-2,900
-29% -$113K
SPHS
46
DELISTED
Sophiris Bio, Inc.
SPHS
$211K 0.21%
93,900
– –
KTOS icon
47
Kratos Defense & Security Solutions
KTOS
$10.1B
$202K 0.21%
25,900
+6,900
+36% +$53.6K
MWV
48
DELISTED
MEADWESTVACO CORP
MWV
$164K 0.17%
+3,700
New +$150K
SRCI
49
DELISTED
SRC Energy Inc
SRCI
$156K 0.16%
11,800
– –
WPRT
50
Westport Fuel Systems
WPRT
$35.1M
$150K 0.15%
830
-830
-50% -$124K
1
2
3 4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Sophrosyne Capital held 92 positions worth $98.2M, down 14% from $114M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Sophrosyne Capital withdrew a net $12.8M in Q2 2014, closing 27 positions and reducing 24 holdings. Its most notable exit was Syngenta Ag, an estimated $6.05M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Technology and Financials.

Against the trend, Sophrosyne Capital opened a new position in DURECT Corp worth $2.31M.

  • Sophrosyne Capital's largest Q2 2014 buy was DURECT Corp: 126,902 shares worth $2.31M.
  • Sophrosyne Capital added most to Rentech, Inc. in Q2 2014, an estimated $1.66M increase.
  • Sophrosyne Capital's biggest Q2 2014 reduction was BioDelivery Sciences International, Inc., cutting an estimated $1.16M.
  • Sophrosyne Capital fully exited Syngenta Ag in Q2 2014, selling an estimated $6.05M.
  • Sophrosyne Capital's ten largest holdings make up 57% of its $98.2M portfolio in Q2 2014.
  • Sophrosyne Capital opened 14 new positions and closed 27 in Q2 2014.
  • Sophrosyne Capital's portfolio value fell 14% quarter-over-quarter to $98.2M.

Based on Sophrosyne Capital's 13F filing for Q2 2014, filed 14 Aug 2014.